Tarsus Pharmaceuticals (TARS) Gross Profit (2021 - 2026)
Tarsus Pharmaceuticals (TARS) recorded Gross Profit of $180.68 million in Q3 2026, up 63.7% from $110.39 million a year earlier and up 11.7% from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Gross Profit (2021 - 2026) Analysis & Trends
On a TTM basis, Tarsus Pharmaceuticals' Gross Profit came in at $635.87 million as of Sep 30, 2026, up 86.2% year-over-year; for FY2025, it came in at $420.68 million, up 147.3% from FY2024.
- Annual Gross Profit has a four-year compound annual growth rate of 66.3% (FY2021 to FY2025).
- Across earlier years, Gross Profit came in at $170.13 million in FY2024 (+973.1%), $15.85 million in FY2023 (-36.2%), $24.86 million in FY2022 (-54.8%) and $54.95 million in FY2021.
- The Q3 2026 figure is the highest quarterly Gross Profit in data going back to Q1 2021.
- On a year-over-year basis, Gross Profit has increased for eight consecutive quarters, with growth averaging 158.8% over the last eight quarters.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 938.4% in Q1 2024, against a decline of 98.4% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $161.8 million (Q2 2026), $152.66 million (Q1 2026) and $140.74 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Tarsus Pharmaceuticals | 3.64 Bn | 2.07 Bn | 180.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 180.68 Mn |
| Jun 30, 2026 | 161.80 Mn |
| Mar 31, 2026 | 152.66 Mn |
| Dec 31, 2025 | 140.74 Mn |
| Sep 30, 2025 | 110.39 Mn |
| Jun 30, 2025 | 96.42 Mn |
| Mar 31, 2025 | 73.12 Mn |
| Dec 31, 2024 | 61.48 Mn |
| Sep 30, 2024 | 44.88 Mn |
| Jun 30, 2024 | 37.81 Mn |
| Mar 31, 2024 | 25.96 Mn |
| Dec 31, 2023 | 11.86 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Mar 31, 2023 | 2.50 Mn |
| Dec 31, 2022 | 9.60 Mn |
| Jun 30, 2022 | 14.76 Mn |
| Mar 31, 2022 | 506,000.00 |
| Dec 31, 2021 | 362,000.00 |
| Sep 30, 2021 | 1.18 Mn |
| Jun 30, 2021 | 21.28 Mn |
API Access
Tarsus Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();